Base editing, a new form of gene therapy, leaves patient feeling ‘more than fine’
Branden Baptiste, diagnosed with sickle cell disease at a young age, struggled with chronic complications affecting his kidneys, lungs, joints, and eyes. Seeking a cure, he participated in a groundbreaking gene therapy trial called BEACON at Boston Children’s Hospital. Through base editing, the most precise form of gene therapy, Branden’s red blood cells were edited…